| 今开：5.59 | 昨收：5.61 |
| 最高：5.785 | 最低：5.3112 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2.905165E7 |
Aprea Therapeutics(APRE)04-11 04:25
$Aprea Therapeutics(APRE)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001558370-24-004927 Act: 34 Size: 7 MB 网页链接查看全文
Aprea Therapeutics(APRE)03-29 06:05
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-040645 Size: 7 KB 网页链接查看全文
Aprea Therapeutics(APRE)04-04 04:15
$Aprea Therapeutics(APRE)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001104659-24-043099 Act: 33 Size: 465 KB 网页链接查看全文
Aprea Therapeutics(APRE)03-29 06:05
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-040642 Size: 9 KB 网页链接查看全文
Aprea Therapeutics(APRE)03-26 20:25
$Aprea Therapeutics(APRE)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001558370-24-003887 Act: 34 Size: 6 MB 网页链接查看全文
Aprea Therapeutics(APRE)03-26 19:55
$Aprea Therapeutics(APRE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-003886 Act: 34 Size: 9 MB 网页链接查看全文
Aprea Therapeutics(APRE)03-15 08:55
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034671 Size: 10 KB 网页链接查看全文
Aprea Therapeutics(APRE)03-15 09:05
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034673 Size: 10 KB 网页链接查看全文
Aprea Therapeutics(APRE)03-15 08:55
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034672 Size: 10 KB 网页链接查看全文
智通财经APP获悉，9月21日(周二)美股开盘，三大指数齐涨。道琼斯指数涨0.38%；纳斯达克综合指数涨0.50%；标普500指数涨0.46%。 个股消息 Aprea Therapeutics(APRE.US)盘初涨2.89%，旗下在研药物1/2期临床试验数据公布。 壳牌(RDS.A.US)... 网页链接
智通财经APP获悉，9月21日(周二)美股盘前，截至北京时间16：35，Aprea Therapeutics(APRE.US)涨18.35%，报5.74美元/股。消息面上，该公司在2021年欧洲肿瘤内科学会年会(ESMO)上，公布了在研药物突变抑制Eprenetapopt用于治疗晚期实体肿... 网页链接
【行情】生物制药公司Aprea Therapeutics(APRE.O)上涨14%，此前美国食品药品监督管理局批准其孤儿药用于白血病治疗。（美港电讯） 生物制药公司Aprea Therapeutics(APRE.O)上涨14%，此前美国食品药品监督管理局批准其孤儿药用于白血病治疗。 网页链接
$Aprea Therapeutics(APRE)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001558370-24-004927 Act: 34 Size: 7 MB 网页链接
$Aprea Therapeutics(APRE)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001104659-24-043099 Act: 33 Size: 465 KB 网页链接
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-040642 Size: 9 KB 网页链接
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-040645 Size: 7 KB 网页链接
$Aprea Therapeutics(APRE)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001558370-24-003887 Act: 34 Size: 6 MB 网页链接
$Aprea Therapeutics(APRE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-003886 Act: 34 Size: 9 MB 网页链接
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034673 Size: 10 KB 网页链接
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034672 Size: 10 KB 网页链接
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034671 Size: 10 KB 网页链接
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034670 Size: 10 KB 网页链接